DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,041,030 | -7.3% | 4,500 | -0.6% | 0.34% | -17.1% |
| Q3 2023 | $1,122,653 | +2.0% | 4,525 | -1.3% | 0.42% | +4.8% |
| Q2 2023 | $1,100,400 | -10.5% | 4,585 | -6.0% | 0.40% | -13.7% |
| Q1 2023 | $1,229,955 | -3.2% | 4,880 | +2.0% | 0.46% | -10.9% |
| Q4 2022 | $1,270,035 | +1.0% | 4,785 | -1.7% | 0.52% | -10.4% |
| Q3 2022 | $1,258,000 | -0.4% | 4,870 | -2.2% | 0.58% | +5.3% |
| Q2 2022 | $1,263,000 | -16.8% | 4,980 | -3.8% | 0.55% | -6.7% |
| Q1 2022 | $1,518,000 | -16.1% | 5,175 | -5.9% | 0.59% | -12.4% |
| Q4 2021 | $1,810,000 | +8.1% | 5,500 | 0.0% | 0.67% | -0.9% |
| Q3 2021 | $1,674,000 | +9.9% | 5,500 | -3.1% | 0.68% | +6.8% |
| Q2 2021 | $1,523,000 | +18.2% | 5,675 | -0.9% | 0.63% | +10.5% |
| Q1 2021 | $1,289,000 | -4.1% | 5,725 | -5.4% | 0.57% | -12.4% |
| Q4 2020 | $1,344,000 | -0.5% | 6,050 | -3.6% | 0.65% | -13.4% |
| Q3 2020 | $1,351,000 | +21.7% | 6,275 | 0.0% | 0.75% | +12.5% |
| Q2 2020 | $1,110,000 | +23.9% | 6,275 | -3.1% | 0.67% | +5.7% |
| Q1 2020 | $896,000 | -19.1% | 6,475 | -10.3% | 0.63% | +1.9% |
| Q4 2019 | $1,108,000 | -2.9% | 7,219 | -8.6% | 0.62% | -13.4% |
| Q3 2019 | $1,141,000 | +0.4% | 7,897 | -0.6% | 0.72% | -0.8% |
| Q2 2019 | $1,136,000 | +7.6% | 7,947 | -0.6% | 0.72% | +5.2% |
| Q1 2019 | $1,056,000 | +28.2% | 7,997 | 0.0% | 0.69% | +22.0% |
| Q4 2018 | $824,000 | -5.1% | 7,997 | 0.0% | 0.56% | +9.1% |
| Q3 2018 | $868,000 | +0.5% | 7,997 | -8.7% | 0.52% | -8.2% |
| Q2 2018 | $864,000 | +31.9% | 8,763 | +30.9% | 0.56% | +25.4% |
| Q1 2018 | $655,000 | -8.5% | 6,692 | -13.3% | 0.45% | +2.5% |
| Q4 2017 | $716,000 | -63.9% | 7,722 | -66.6% | 0.44% | -66.0% |
| Q3 2017 | $1,984,000 | +1.4% | 23,139 | -0.3% | 1.29% | -2.6% |
| Q2 2017 | $1,957,000 | +1.0% | 23,199 | +2.4% | 1.32% | -2.4% |
| Q1 2017 | $1,937,000 | +14.2% | 22,649 | +3.9% | 1.36% | +4.5% |
| Q4 2016 | $1,696,000 | -0.2% | 21,799 | +0.5% | 1.30% | -4.9% |
| Q3 2016 | $1,700,000 | -23.8% | 21,699 | -1.8% | 1.36% | -26.5% |
| Q2 2016 | $2,232,000 | +4.7% | 22,099 | -1.7% | 1.86% | -1.1% |
| Q1 2016 | $2,132,000 | +3.9% | 22,479 | +1.8% | 1.88% | -0.2% |
| Q4 2015 | $2,051,000 | +11.9% | 22,079 | +2.6% | 1.88% | -3.8% |
| Q3 2015 | $1,833,000 | -1.8% | 21,514 | -1.4% | 1.95% | +6.4% |
| Q2 2015 | $1,867,000 | -0.6% | 21,814 | -1.4% | 1.84% | +233.4% |
| Q1 2015 | $1,879,000 | +2.4% | 22,134 | +3.4% | 0.55% | +5.2% |
| Q4 2014 | $1,835,000 | +13.2% | 21,409 | +0.4% | 0.52% | +9.2% |
| Q3 2014 | $1,621,000 | +0.2% | 21,334 | +3.8% | 0.48% | +0.4% |
| Q2 2014 | $1,618,000 | +11.1% | 20,555 | +5.8% | 0.48% | +4.1% |
| Q1 2014 | $1,457,000 | -14.3% | 19,433 | -11.8% | 0.46% | -17.6% |
| Q4 2013 | $1,701,000 | +6.4% | 22,033 | -4.5% | 0.56% | -3.8% |
| Q3 2013 | $1,599,000 | +8.3% | 23,065 | -1.1% | 0.58% | -4.8% |
| Q2 2013 | $1,477,000 | – | 23,329 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |